u/emil_wojcik

Agreed on the swirl. There is no reason to shake it and a good reason not to.

Logged the missed weeks as blanks rather than skipping them. The gaps turned out to be the informative part.

Asked somebody qualified locally rather than relying on this board. Best forty minutes I have spent on the topic.

Chased the scale instead of the measurements for a year and made myself miserable for no additional progress.

Reconstituted at 3mL when I meant to use a different volume. Caught it because the units looked wrong on the barrel. Now I write 5mg/mL on the glass before I put the cap back.

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.

dual agonist, so the GIP arm is doing something the sema threads will not tell you about

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

the four-week step schedule is the label, not folklore

How long have you been on the list, and from what date?

Careful — posting a log as a schedule for other people to follow is not what this board is for.

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

Agree. The GIP component is the interesting half and it barely gets discussed outside c/glp1science.

phase 2 data only, and people quote it like it is a label

Cosigning that going too fast is the most repeated regret on the whole site.

reconstituting at a round concentration makes every later dose easy

Asked the pharmacist to check the wholesaler and had a definite answer in about four minutes.

Kept the script and the receipt for a private health claim and both were requested.

Checked the shortage database myself instead of reading the coverage. Expected resolution date was right there and the panic thread was wrong.

units are a volume on a U-100 syringe, not a dose

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

Is this about registration or about subsidy?

Agreed. The ICB variation is the thing that makes national advice useless here.

research-use-only labelling is not a customs category

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 22 is not a fair reading.

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

Is this the first time, or a pattern you can see now?

Have you asked the supplier what they declare?

Cosigning the domain check. Character by character, every time, and paste it rather than typing it.

The lyophilised cake displaces a small volume, so the true concentration is very slightly lower than the arithmetic suggests. It is a fraction of a percent and it is dwarfed by fill tolerance.

a lot of the confident posting here is extrapolation

Yes — log what happened rather than what you intended. My retrospective entries were quietly wrong every time.

the phase 2 numbers were striking and they were also 48 weeks in a small population

switching from sema is not a dose conversion, there is no clean equivalence

I would not read a single clearance experience as a rule. Sample size one, and customs is not deterministic.

Contemporaneous records do not drift; reconstructed ones do, and the drift is systematic rather than random because memory smooths.